Marshall Wace
LMAT icon

Marshall Wace’s LeMaitre Vascular LMAT Stock Holding History

Marshall Wace’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.59M Sell
37,402
-93,818
-71% -$9.62M ﹤0.01% 1547
2026
Q1 		$14.3M Buy
131,220
+82,992
+172% +$7.91M 0.01% 817
2025
Q4 		$3.91M Sell
48,228
-28,122
-37% -$2.42M ﹤0.01% 1267
2025
Q3 		$6.68M Sell
76,350
-34,158
-31% -$3.05M 0.01% 1084
2025
Q2 		$9.18M Sell
110,508
-15,466
-12% -$1.29M 0.01% 871
2025
Q1 		$10.6M Buy
125,974
+86,188
+217% +$8.02M 0.01% 751
2024
Q4 		$3.67M Buy
39,786
+37,346
+1,531% +$3.59M ﹤0.01% 1196
2024
Q3 		$227K Sell
2,440
-22,579
-90% -$1.96M ﹤0.01% 2257
2024
Q2 		$2.06M Sell
25,019
-19,921
-44% -$1.46M ﹤0.01% 1356
2024
Q1 		$2.98M Sell
44,940
-38,432
-46% -$2.37M ﹤0.01% 1198
2023
Q4 		$4.73M Sell
83,372
-13,564
-14% -$711K 0.01% 935
2023
Q3 		$5.28M Buy
96,936
+33,702
+53% +$2M 0.01% 848
2023
Q2 		$4.25M Buy
+63,234
New +$3.86M 0.01% 1098
2021
Q2 		– Sell
-9,326
Closed -$455K – 2875
2021
Q1 		$455K Sell
9,326
-37,568
-80% -$1.76M ﹤0.01% 1980
2020
Q4 		$1.9M Buy
46,894
+10,195
+28% +$364K 0.01% 975
2020
Q3 		$1.19M Buy
36,699
+12,349
+51% +$371K 0.01% 966
2020
Q2 		$643K Buy
+24,350
New +$637K ﹤0.01% 1123
2019
Q4 		– Sell
-20,728
Closed -$708K – 1914
2019
Q3 		$708K Sell
20,728
-115,616
-85% -$3.69M 0.01% 1018
2019
Q2 		$3.81M Sell
136,344
-24,431
-15% -$679K 0.03% 568
2019
Q1 		$4.98M Buy
160,775
+42,560
+36% +$1.14M 0.05% 478
2018
Q4 		$2.79M Buy
+118,215
New +$3.23M 0.03% 646

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace's LMAT Position: Q2 2026 in Review

Marshall Wace reduced its LeMaitre Vascular (LMAT) stake by 71% in Q2 2026, selling an estimated $9.62M and leaving 37,402 shares worth $3.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1547.

Marshall Wace first reported a position in LMAT in Q4 2018 and has held it in 21 quarters since. The position peaked at $14.3M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Marshall Wace held 37,402 shares of LeMaitre Vascular worth $3.59M as of Q2 2026.
  • Marshall Wace sold 93,818 LeMaitre Vascular shares in Q2 2026, an estimated $9.62M.
  • LeMaitre Vascular made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1547 holding.
  • Marshall Wace first reported a position in LeMaitre Vascular in Q4 2018 and has held it in 21 quarters since.
  • Marshall Wace's LeMaitre Vascular position peaked at $14.3M in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.